Iovance Biotherapeutics Inc (IOVA)

[jondoeuk]

From a new PDF: ''IOV-2001 is a non-genetically modified, polyclonal T cell product called PBL.

IOV-2001 can be reproducibly generated from 50 mL of blood over a 9-day manufacturing duration to
yield billions of PBLs.

IOV-2001 demonstrated superior cytotoxicity against autologous tumor (leukemia) cells.

First-in-patient testing of IOV-2001 is planned for the treatment of CLL/SLL patients.

Future testing of this approach in broader array of hematologic malignancies is being explored.'' https://www.iovance.com/wp-content/uploads/Iovance_EHA2019_poster_FINAL_20190607.pdf